Skip to main content
. 2021 Feb 27;21:90. doi: 10.1186/s12876-021-01667-y

Table 2.

Comparison of self-reported symptomsa between cases and controls

Cases: Celiac disease antibody positive participantsb Controls OR (95% CI)c
Number of participants 169 676
% (n/total N) % (n/total N)
Tiredness
 Yes 29.9 (50/167) 26.9 (180/670) 1.14 (0.79–1.66)
 No 70.1 (117/167) 73.1 (490/670) Ref
Self-perceived health
 Very good/excellent 26.2 (38/145) 30.1 (178/592) Ref
 Good 66.2 (96/145) 57.6 (341/592) 1.37 (0.90–2.10)
 Fair/poor 7.6 (11/145) 12.3 (73/592) 0.73 (0.35–1.52)
Headache
 Yes 54.4 (81/149) 51.1 (314/615) 1.32 (0.80–2.18)
 No 45.6 (68/149) 48.9 (301/615) Ref
Abdominal pain
 Yes 24.9 (41/165) 27.1 (181/669) 0.92 (0.62–1.37)
 No 75.2 (124/165) 72.9 (488/669) Ref
Bloating
 Yes 65.8 (77/117) 64.0 (301/470) 1.12 (0.72–1.74)
 No 34.2 (40/117) 36.0 (169/470) Ref
Reflux
 Yes 44.3 (31/70) 39.0 (112/287) 1.26 (0.73–2.17)
 No 55.7 (39/70) 61.0 (175/287) Ref
Rumbling
 Yes 42.0 (66/157) 42.3 (294/622) 0.82 (0.57–1.18)
 No 58.0 (91/157) 52.7 (328/622) Ref
Alternating stool
 Yes 68.0 (106/156) 67.6 (421/623) 1.02 (0.69–1.51)
 No 32.1 (50/156) 32.4 (202/623) Ref
Nausea
 Yes 23.8 (10/42) 20.4 (34/167) 1.23 (0.54–2.82)
 No 76.2 (32/42) 79.6 (133/167) Ref

aThe information on self-reported symptoms were collected in questionnaires answered by the participants prior to examination and blood sample collection

bThe participants were screened for celiac disease antibodies by EliA™ Celikey® tissue transglutaminase (TTG) anti-IgA and anti-IgG assays and deamidated gliadin peptide (DGP) anti-IgG assays. Celiac disease antibody positive were defined as IgG-DGP ≥ 10.0 U/mL and/or IgA-TTG/IgG-TTG ≥ 7.0 U/mL. 5 of the 16,776 participants had a diagnosis of celiac disease in the national patient register, they were all celiac disease antibody negative and were excluded before matching. Cases were matched without replacement on age (5 years range), sex and study to 4 controls

cConditional logistic regression for comparison of cases with controls giving odds ratios (ORs) with 95% confidence intervals (CIs)